<scp>GLOBE</scp> Score and <scp>UK</scp>‐<scp>PBC</scp> Risk Score Predict Long‐Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate
The GLOBE and UK-PBC risk scores outperformed the other biochemical response criteria in predicting the clinical outcomes of PBC patients with suboptimal response to UDCA and receiving fenofibrate add-on therapy.
Authors
- Jidong Jia (ORCID: https://orcid.org/0000-0002-4673-8890)
- Qian Yi Wang
- Yuanyuan Kong (ORCID: https://orcid.org/0000-0002-2586-1443)
- Xiao Ming Wang (ORCID: https://orcid.org/0000-0002-7483-6682)
- Xinyan Zhao (ORCID: https://orcid.org/0000-0002-8016-4368)
- Hong Mā (ORCID: https://orcid.org/0000-0001-8717-4422)
- Shu Xiang Li
- Hong You (ORCID: https://orcid.org/0000-0001-9409-1158)
- Wei Duan (ORCID: https://orcid.org/0009-0008-2873-6163)
- Man Li (ORCID: https://orcid.org/0000-0002-3839-0281)
- Sha Chen (ORCID: https://orcid.org/0000-0002-8683-8677)
- Yu Wang (ORCID: https://orcid.org/0000-0002-8636-9540)
- T T Lyu
- Xiao Juan Ou
- Bu Er Li
Institutions
- Capital Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Institut de Recherche en Santé Digestive (FR)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Journal of Digestive Diseases
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1111/1751-2980.13359
- Citations
- 1
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- National Natural Science Foundation of China